Cenestra

Cenestra was a consumer healthcare and nutraceutical company focused on the development and commercialization of high-purity omega-3 fatty acid supplements, specifically docosahexaenoic acid (DHA). The company's primary product line, including brands like Cenestin and various DHA formulations, targeted cognitive health, prenatal nutrition, and developmental disorders such as ADHD. Cenestra emphasized pharmaceutical-grade manufacturing standards for its supplement products to ensure high bioavailability and purity. While the company was active in the early to mid-2000s, its operations have since ceased or been absorbed into other entities.